Sean Hall

Chief Executive Officer, Managing Director

Sean Hall Portrait

Sean Hall founded Medlab in August 2012. Sean has over 20 years experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.

Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance BioCeuticals became the most innovative, research driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management, and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.

Alan Dworkin

Chief Financial Officer, Company Secretary

Alan Dworkin Portrait

Alan Dworkin is a chartered accountant with over 18 years experience in the tax, retail, resources and nutraceutical/pharmaceutical sectors. Alan was the CFO and Company Secretary of FIT-Bioceuticals Limited for over six years and also has had experience in ASX listed companies within the resources sector, most recently as Company Secretary of Uramet Minerals Limited. Alan has been the Chief Financial Officer and Company Secretary for Medlab Clinical Limited since February 2015.

Alan is a member of the Institute of Chartered Accountants in Australia, the Governance Institute in Australia and the Australian Institute of Company Directors.

Luis Vitetta

Director of Medical Research

Luis Vitetta Portrait

Luis Vitetta is Director of Medical Research at Medlab and Adjunct Professor at the University of Sydney, Sydney Medical School. Luis has deep knowledge of the science behind effective probiotics and biologic medicines. His focus on clinical research and its relevance to commercialisation informs Medlab's product portfolio.

After many years of educating clinicians, pharmacists, undergraduate and postgraduate students, Luis is in a strong position to advance Medlab's clinical research activities and drug innovation projects to the clinical practitioner community.

Dr David Rutolo

Director of Science

David Rutolo Portrait

David has 35 years experience in research, product development, manufacturing, and technical marketing support in the pharmaceutical and nutritional industry. He earned his PhD in organic chemistry at the University of California at Irvine and a JD from Western State University, College of Law. In addition, he holds a Certificate of Completion in FDA Law from the University of Southern California.

David is a major contributor to the American functional food and high-profile bottled juice market segments, and he continues to develop healthcare products specifically designed for the international marketplace. Through a number of private development associations, he consults and formulates nutritional products for Asia, Europe South America and Australia.

David was Cofounder of Micelle Laboratories, Inc., where he served for over 20 years as Executive Vice-President and as a Board Member. The firm provides pharmaceutical and nutritional product development and manufacturing in an FDA drug-licensed facility. As a formulator, he developed unique functional foods, nutritional supplements, skin care formulations, veterinary formulas, and OTC products for domestic and foreign companies. At Micelle, he pioneered the development of micellization, a specialised and patented delivery system to enhance the absorption of fat-soluble substances, widely utilised by organisations in the production of nutritional and skin care preparations.

David manages and is a shareholder of lnMed Technologies, Medlab's 60% owned US company.

Ian Curtinsmith

Chief Information Officer

Ian Curtinsmith Portrait

Ian joined Medlab in July 2019, a strategic executive with C level success in IT governance and Business Intelligence solutions, with 20 years' of experience in Management.

Prior to Medlab, Ian served over 9 years as an Executive Team member of FIT-BioCeuticals, the parent company of brands: BioCeuticals, IsoWhey, Wheyless, PharmaFoods, Hall Drug Technologies, Fusion Health and Oriental Botanicals; a division of Blackmores Ltd (BKL:ASX) which operates in the Vitamin and Supplement industry. Ian was responsible for all Digital and Technology decisions within these businesses including strategic planning, business Integration, risk assessment, security, disaster recovery and change management.

Ian has also implemented projects for large enterprises including GSM/Vodafone, Chartered Accounts, OfficeWorks, Clemenger and Colonial. In addition, Ian has provided outsourcing alternatives and consultation to small and medium businesses as well as acting as a consultant for the music industry, television and production companies. Ian also served on the IT and Marketing committee of the International Probiotic Association (IPA).

Ian is a graduate member of the Australian Institute of Company Directors and holds an Associate Diploma in Electrical Technology.

Tony Potter

General Manager Pharmaceuticals, Commercialisation & Education

Tony Potter Portrait

Tony is a Pharmaceutical Executive with almost 30 years Sales and Marketing experience in small, medium and large companies in both New Zealand and Australia. He holds an Honours Degree in Pharmacology as well as a Post-Graduate qualification in Business and has experience across the full sales and marketing spectrum from field sales representative, through product management, sales and marketing management to commercial director.

Tony has been responsible for leading several successful sales and marketing teams which have resulted in significant growth of multiple products, including launching new products, in both general practice and specialist arenas.